Invasive Candida infections in surgical patients in intensive care units: A prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008)

Clinical Microbiology and Infection

Volumn 21, Issue 1, 2015, Pages 87.e1-87.e10

  Klingspor, L ^a   Tortorano, A M ^b   Peman, J ^c   Willinger, B ^d   Hamal, P ^e   Sendid, B ^f   Velegraki, A ^g   Kibbler, C ^h   Meis, J F ^i,j   Sabino, R ^k   Ruhnke, M ^l   Arikan Akdagli, S ^m   Salonen, J ⁿ   Doczi I ^o  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY OF ATHENS   (Greece)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m HACETTEPE UNIVERSITY   (Turkey)

ⁿ PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^o UNIVERSITY OF SZEGED   (Hungary)

more..

Author keywords

Candida; Candidaemia; Epidemiology; Invasive candidosis; Surgical intensive care

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; VORICONAZOLE; ANTIFUNGAL AGENT;

ABDOMINAL SURGERY; ADULT; ARTICLE; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CENTRAL VENOUS CATHETER; EUROPEAN; FEMALE; HEALTH CARE SURVEY; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA; MYCOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SURGICAL PATIENT; ADOLESCENT; AGED; ANTIBIOTIC PROPHYLAXIS; CANDIDA; CANDIDIASIS, INVASIVE; CHILD; CLINICAL TRIAL; INFANT; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; SURGERY; VERY ELDERLY; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; YOUNG ADULT;

EID: 84926312990     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.08.011     Document Type: Article

References (31)

1. Leleu G., Aegerter P., Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. JCrit Care 2002, 17:168-175.
2. Arendrup M.C., Sulims S., Holm A., Nielsen L., Nielsen S.D., Knudsen J.D., et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. JClin Microbiol 2011, 49:3300-3308.
3. Zaoutis T.E., Argon J., Chu J., Berlin J.A., Walsh T.J., Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41:1232-1239.
4. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzen R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
5. Leroy O., Gangneux J.P., Montravers P., Mira J.P., Gouin F., Sollet J.P., et al. AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009, 37:1612.
6. Tortorano A.M., Peman J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., et al. Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 23:317-322.
7. Tortorano A.M., Dho G., Prigitano A., Breda G., Grancini A., Emmi V., et al. ECMM-FIMUA Study Group: NIAID Mycoses Study Group: Invasive fungal infections in the intensive care unit: a multicenter, prospective, observational study in Italy (2006-2008). Mycoses 2012, 55:73-79.
8. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
9. Suetens C., Morales I., Savey A., Palomar M., Hiesmayr M., Lepape A., et al. European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. JHosp Infect 2007, 65:171-173.
10. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., Messer S., et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37:1172-1177.
11. Sendid B., Cotteau A., Francois N., D'Haveloose A., Standaert A., Camus D., et al. Candidemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis 2006, 6:80.
12. De Pauw B.W.T., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 47:674-683.
13. Bougnoux M.E., Kac G., Aegerter P., d'Enfert C., Fagon J.Y. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008, 34:292-299. CandiRea Study Group.
14. Kett D.H., Azoulay E., Echeveirria P.M., Vincent J.L. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011, 39:665-670.
15. Jensen J., Munoz P., Guinea J., Rodríguez-Créixems M., Peláez T., Bouza E. Mixed fungemia: incidence, risk factors, and mortality in a general hospital. Clin Infect Dis 2007, 44:e109-e114.
16. Arendrup M.C., Bruun B., Christensen J.J., Fuursted K., Johansen H.K., Kjaeldgaard P., et al. National surveillance of fungemia in Denmark (2004 to 2009). JClin Microbiol 2011, 49:325-334.
17. Ericsson J., Chryssanthou E., Klingspor L., Johansson A.G., Ljungman P., Svensson E., et al. Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect 2013, 19:E218-E221.
18. Malani A.N., Psarros G., Malani P.N., Kauffman C.A. Is age a factor for Candida Glabrata colonization. Mycoses 2012, 54:531-537.
19. Montagna M.T., Lovero G., Borghi E., Amato G., Andreoni S., Campion L., et al. Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study)and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Sci 2014, 18:661-674.
20. Steinbach W.J., Roilides E., Berman D., Hoffman J.A., Groll A.H., Bin-Hussain I., et al. International Pediatric Fungal Network: results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012, 31:1252-1257.
21. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
22. Cornely O.A., Bassetti M., Calandra T., Garbino J., Kullberg B.J., Lortholary O., et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012, 18(Suppl.7):19-37.
23. Andes D.R., Safdar N., Baddley J.W., Playford G., Reboli A.C., Rex J.H., et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials. Clin Infect Dis 2012, 54:1110-1122.
24. Weinberger M., Leibovici L., Perez S., Samra Z., Ostfeld I., Levi I., et al. Characteristics of candidaemia with C.albicans compared with non-albicans species and predictors of mortality. JHosp Infect 2005, 61:146-154.
25. Rodriguez D., Park B.J., Almirante B., Cuenca-Estrella M., Planes A.M., Mensa J., et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect 2009, 58:154-160.
26. Paulitsch A.H., Willinger B., Zsalatz B., Stabentheiner E., Marth E., Buzina W. In-vivo Candida biofilms in scanning electron microscopy. Med Mycol 2009, 47:690-696.
27. Agvald-Öhman C., Klingspor K., Hjelmqvist H., Edlund C. Invasive candidiasis in longterm patients at a multidisciplinary Intensive Care Unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2007, 31:1-9.
28. Eggimann P., Bille J., Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 2011 Sep 1, 1:37.
29. Eggimann P., Francioli P., Bille J., Schneider R., Wu M.M., Chapuis G., et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999, 27:1066-1072.
30. Morrell M., Fraser V.J., Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
31. Chong Y., Shimoda S., Yakushiji H., Ito Y., Miyamoto T., Shimono N., et al. Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies. JInfect Chemother 2012, 18:741-746.